Annual report, foreign filer
Open the filing on sec.gov
Basel Medical Group Ltd (BMGL)
Nasdaq: BMGL · Services-Offices & Clinics of Doctors of Medicine · Singapore, SG · filing with the SEC since 2024
The companyfiscal 2025, as filed
RevenueSGD 11.3M+12.6%
Net income-SGD 10.6M-613.1%
Earnings per shareSGD -0.57-538.5%
Operating cash flow-SGD 4.0M-261.2%
CashSGD 3.0M+56.0%
Debtn/a
Shareholders’ equitySGD 5.4M-28.1%
Shares, diluted18.8M+15.6%
Return on equity-195.6%
The recordfrom its filings
Filings in 202630
Newest filingOct 30 · 20-F
Annual reportOct 30, 2026
Quarterly reportn/a
Next report due20-F by Oct 28
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer categoryNon-accelerated filer<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in SGD. Nothing here is a forecast.
News
Interim report, foreign filer
Open the filing on sec.gov
Insider holding, initial
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Offering prospectus
Open the filing on sec.gov
Insider holding, initial
Open the filing on sec.gov
Registration effective
Open the filing on sec.gov
Listing registration, foreign filer, amended
Open the filing on sec.gov
Listing registration, foreign filer
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.